#glp1market — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #glp1market, aggregated by home.social.
-
https://www.europesays.com/dk/35540/ Novo Nordisk’s ‘Semaglutide’ gains weight against Eli Lilly in battle for market share #AntiObesityDrugs #cipla #DiabetesMedication #EliLilly #GLP1Market #MarketShare #NovoNordisk #ozempic #semaglutide #Tirzepatide #Wegovy
-
Novo Nordisk will cut US list prices of its diabetes and obesity drugs Wegovy and Ozempic by up to 50% from January, reflecting intensifying GLP-1 market competition and aligning with Medicare price reforms.
#YonhapInfomax
#NovoNordisk #Wegovy #Ozempic #PriceCut #GLP1Market
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106678 -
Novo Nordisk will cut US list prices of its diabetes and obesity drugs Wegovy and Ozempic by up to 50% from January, reflecting intensifying GLP-1 market competition and aligning with Medicare price reforms.
#YonhapInfomax
#NovoNordisk #Wegovy #Ozempic #PriceCut #GLP1Market
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106678 -
Novo Nordisk will cut US list prices of its diabetes and obesity drugs Wegovy and Ozempic by up to 50% from January, reflecting intensifying GLP-1 market competition and aligning with Medicare price reforms.
#YonhapInfomax
#NovoNordisk #Wegovy #Ozempic #PriceCut #GLP1Market
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106678 -
Novo Nordisk will cut US list prices of its diabetes and obesity drugs Wegovy and Ozempic by up to 50% from January, reflecting intensifying GLP-1 market competition and aligning with Medicare price reforms.
#YonhapInfomax
#NovoNordisk #Wegovy #Ozempic #PriceCut #GLP1Market
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106678